FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code…
Headline
The Cybersecurity and Infrastructure Security Agency has launched a new initiative for critical infrastructure to defend against cyberattacks through proactive…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, will moderate a webinar May 5 at 1 p.m. ET that will explore how bad actors are leveraging…
Headline
The AHA and Joint Commission May 4 announced the launch of the Cyber Resilience Readiness program, an initiative to help hospitals and health systems assess…
Headline
The Cybersecurity and Infrastructure Security Agency, National Security Agency and international partners have released guidance on adopting agentic artificial…
Headline
A joint advisory released April 23 from U.S. and international cybersecurity agencies, including the Cybersecurity and Infrastructure Security Agency, FBI,…